The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence.

COVID-19 SARS-CoV-2 anti-science lab leak origin pandemic science advocacy science policy spillover zoonosis

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 Aug 2024
Historique:
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: aheadofprint

Résumé

Science is humanity's best insurance against threats from nature, but it is a fragile enterprise that must be nourished and protected. The preponderance of scientific evidence indicates a natural origin for SARS-CoV-2. Yet, the theory that SARS-CoV-2 was engineered in and escaped from a lab dominates media attention, even in the absence of strong evidence. We discuss how the resulting anti-science movement puts the research community, scientific research, and pandemic preparedness at risk.

Identifiants

pubmed: 39087765
doi: 10.1128/jvi.01240-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0124024

Auteurs

James Alwine (J)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Felicia Goodrum (F)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Bruce Banfield (B)

Department of Biomedical and Molecular Sciences, Queens University, Kingston, Ontario, Canada.

David Bloom (D)

Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.

William J Britt (WJ)

Department of Pediatrics, University of Alabama, Birmingham, Birmingham, Alabama, USA.

Andrew J Broadbent (AJ)

Department of Animal and Avian Sciences, University of Maryland, College Park, Maryland, USA.

Samuel K Campos (SK)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Arturo Casadevall (A)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

Gary C Chan (GC)

Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York, USA.

Anna R Cliffe (AR)

Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Terence Dermody (T)

Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Paul Duprex (P)

University of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, USA.

Lynn W Enquist (LW)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.

Klaus Frueh (K)

Oregon Health and Science University, Vaccine and Gene Therapy Institute, Beaverton, Oregon, USA.

Adam P Geballe (AP)

Department of Medicine, University of Washington, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Marta Gaglia (M)

Department of Medical Microbiology and Immunology, University of Wisconsin, Institute for Molecular Virology, Madison, Wisconsin, USA.

Stephen Goldstein (S)

Department of Human Genetics, University of Utah School of Medicine, Howard Hughes Medical Institute, Salt Lake City, Utah, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.

Alexander L Greninger (AL)

Department of Medicine, Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

Gigi Kwick Gronvall (GK)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

Jae U Jung (JU)

Cleveland Clinic, Lerner Research Institute, Cleveland, Ohio, USA.

Jeremy P Kamil (JP)

Department of Microbiology and Immunology, Louisiana State University Health Sciences, Shreveport, Louisiana, USA.

Seema Lakdawala (S)

Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.

Shan-Lu Liu (S-L)

The Ohio State University, Center for Retrovirus Research and Infectious Disease Institute, Columbus, Ohio, USA.

Micah Luftig (M)

Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.

John P Moore (JP)

Department of Microbiology and Immunology, Cornell University, Weill Cornell Medicine, New York, New York, USA.

Anne Moscona (A)

Columbia University, Vagelos College of Physicians and Surgeons, New York, New York, USA.

Benjamin W Neuman (BW)

Department of Biology, Texas A&M University, College Station, Texas, USA.

Janko Ž Nikolich (JŽ)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Christine O'Connor (C)

Cleveland Clinic, Lerner Research Institute, Cleveland, Ohio, USA.

Andrew Pekosz (A)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

Sallie Permar (S)

Department of Pediatrics, Cornell University, Weill Cornell Medicine, New York, New York, USA.

Julie Pfeiffer (J)

University of Texas, Southwestern Medical Center, Dallas, Texas, USA.

John Purdy (J)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Angela Rasmussen (A)

University of Saskatchewan, College of Medicine, Saskatoon, Canada.

Bert Semler (B)

Department of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, California, USA.

Gregory A Smith (GA)

Department of Microbiology and Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

David A Stein (DA)

Oregon State University, Carlson College of Veterinary Medicine, Corvallis, Oregon, USA.

Koenraad Van Doorslaer (K)

Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.

Sandra K Weller (SK)

Department of Molecular Biology and Biophysics, University of Connecticut, Farmington, Connecticut, USA.

Sean P J Whelan (SPJ)

Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

Andrew Yurochko (A)

Department of Microbiology and Immunology, Louisiana State University Health Sciences, Shreveport, Louisiana, USA.

Classifications MeSH